Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on May 29, 2018, with the earliest event reported on that date. The filing details corporate actions approved by stockholders at the 2018 Annual Meeting on May 18, 2018, specifically regarding a reverse stock split and amendments to the Company's Certificate of Incorporation.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and capital structure adjustments rather than operational financial performance.
Material Changes
- Reverse Stock Split: The Board approved a 1-for-15 reverse stock split of issued and outstanding Common Stock. This became effective on June 1, 2018. Every 15 pre-split shares were reclassified into 1 post-split share. No fractional shares were issued; cash was paid in lieu of fractional shares.
- Authorized Share Reduction: The total number of authorized shares was amended to 210,000,000. This consists of 150,000,000 shares of Common Stock, 50,000,000 shares of non-voting common stock, and 10,000,000 shares of "blank check" preferred stock.
- Trading Adjustments: Commencing June 1, 2018, trading on The NASDAQ Capital Market resumed on a reverse stock split-adjusted basis under the new CUSIP number 47010C300.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future financial performance, or specific risk factors beyond the standard disclosure regarding the mechanics of the stock split. Computershare Trust Company, N.A. was appointed as the exchange agent to handle certificate exchanges.
Key Facts for Investor Verification
- Verify the effective date of the 1-for-15 reverse stock split (June 1, 2018).
- Confirm the new CUSIP number for trading purposes (47010C300).
- Check the new authorized share structure: 150M Common, 50M Non-voting Common, 10M Preferred.
- Review the treatment of fractional shares (cash payment in lieu of issuance).
- Confirm that stockholders holding shares in "street name" do not need to take action to effect the exchange.